Cargando…
The cancer epigenome: Non‐cell autonomous player in tumor immunity
Dysregulation of the tumor‐intrinsic epigenetic circuit is a key driver event for the development of cancer. Accumulating evidence suggests that epigenetic and/or genetic drivers stimulate intrinsic oncogenic pathways as well as extrinsic factors that modulate the immune system. These modulations in...
Autores principales: | Kato, Shinichiro, Maeda, Yuka, Sugiyama, Daisuke, Watanabe, Keisuke, Nishikawa, Hiroyoshi, Hinohara, Kunihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986067/ https://www.ncbi.nlm.nih.gov/pubmed/36468774 http://dx.doi.org/10.1111/cas.15681 |
Ejemplares similares
-
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal
por: Isoyama, Sho, et al.
Publicado: (2021) -
Endocrine disrupters: the new players able to affect the epigenome
por: Casati, Lavinia, et al.
Publicado: (2015) -
Immune epigenome
por: Bird, Lucy
Publicado: (2021) -
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
por: Tanaka, Atsushi, et al.
Publicado: (2019) -
Selective inhibition of low-affinity memory CD8(+) T cells by corticosteroids
por: Tokunaga, Akihiro, et al.
Publicado: (2019)